The Foundation supports research across basic, translational and clinical science to speed breakthroughs that can lead to the creation of new treatments and a better quality of life for people with Parkinson's disease.
Search or browse funded studies
Previously funded studies appear chronologically, with the most recent appearing first.
-
Magnetic Resonance Imaging Biomarkers, 2022Use of Novel Intestinal Imaging for Early Identification of Parkinson’s Disease and Assessment of Response to Therapies that Reduce Alpha-synuclein Accumulation
Study Rationale: Changes in intestinal contractions are a common feature of early Parkinson’s disease (PD). These changes, which often occur before the onset of movement symptoms, are tied to the...
-
Magnetic Resonance Imaging Biomarkers, 2022Dynamic Modeling and Prediction of Parkinsonian Symptom Progression
Study Rationale: Parkinson’s disease (PD) affects different people in different ways. We believe that these differences can offer clues about what happens in the brain before people with PD even begin...
-
Research Grant, 2022Identifying Novel Target Genes and Compounds for Controlling the Motor Symptoms of Parkinson’s Disease
Study Rationale: Understanding neurological conditions has been among the most difficult challenges in modern medicine. The brain contains more than 86 billion nerve cells that form the neural...
-
Summer 2022 RFP: The Edmond J. Safra Movement Disorders Research Career Development Award, 2022Tracking Eye Movements and Pupil Responses as a Diagnostic and Prognostic Biomarker in Parkinsonian Disorders
Study Rationale: We do not currently have accurate tests to diagnose Parkinson’s disease (PD) and the conditions which mimic it (atypical parkinsonism) at a very early stage. Similarly, we do not have...
-
Research Resources, 2022Neural Network Imaging Analysis in Parkinson’s Disease Associated with Parkin Mutation
Study Rationale: Clinical imaging biomarkers are desperately needed to provide a non-invasive means of assessing therapeutic efficacy in clinical trials for Parkinson’s disease (PD). Recent studies...
-
Fall 2020 RFA: Therapeutic Pipeline Program-Pre-Clinical, 2022Assessing a Novel Strategy for Noninvasive Stimulation of Dopamine-producing Neurons in Preclinical Models of Parkinson’s Disease
Rationale: Parkinson’s disease (PD) is caused by the progressive degeneration of the dopamine-producing neurons responsible for initiating and refining voluntary movements. Treatments based on drugs...
Apply for a Grant
Our funding programs support basic, translational and clinical research from academia and industry.